unilife - still bullish after q2 2014 earnings, page-12

Hi,
I have come up with a new take on the unilife puzzle. Please note , I am an enthusiast amateur, who is looking at the puzzle from a different angle.

The latest figures show that UNS is still burning a lot of money every quarter, and most of that is invested heavily in R&D. Based on the recent conference call pertaining to the 2nd quarters financials , over 50 % of the money invested in R&D was spent on current active contracts, which have already been announced.

Which leads me to believe , that up front payments / milestone payments can only do so much!!, still leaving UNS with substantial financial obligations, to see these current contracts off the ground and into full scale production which as we all know take some time.

My conclusion for all of UNS delays, lack of information
And very broad statements, is not the pharamacuticals fault or lack of interest in the products, it's because unilife simply cannot afford to take on anymore contracts / financial obligations at this stage. they know they can't meet new financial obligations .

AL also knows that doing a capital raising or tapping into the ATM will take them out the favourable position which they are in and put them into a unfavourable position which comes at a price.
Less hast and more patience will hold better value for UNS at this stage.

So I am convinced that once the debt financing scheme is put in place and hikma starts initial sales in July, all of those contracts that have been stacking up over recent time , will be announced and the chart will go wild breaking through resistant levels that we have been waiting for.


Good night all
Sirsmig